M-10086-A-G

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4 BP6_Moderate BS1 BS2

The ENST00000361227.2(MT-ND3):c.28A>G(p.Asn10Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.

• Frequency: Mitomap GenBank: 𝑓 0.0076 (AC: 465)
• Consequence: MT-ND3 ENST00000361227.2 missense
• Scores: Apogee2 Benign 0.28
• Clinical Significance: Benign criteria provided, single submitter B:1 Hypertensive-end-stage-renal-disease
• Conservation: PhyloP100: 1.06

Genes affected

MT-ND3 (HGNC:7458): (mitochondrially encoded NADH dehydrogenase 3) Enables NADH dehydrogenase (ubiquinone) activity. Involved in mitochondrial electron transport, NADH to ubiquinone. Part of mitochondrial respiratory chain complex I. Implicated in Leber hereditary optic neuropathy; Leigh disease; and Parkinson's disease. [provided by Alliance of Genome Resources, Apr 2022]

MT-TG (HGNC:7486): (mitochondrially encoded tRNA glycine)

TRNG (HGNC:):

ACMG classification

Verdict is Benign. Variant got -11 ACMG points.

• BP4: Apogee2 supports a benign effect, 0.2789152 < 0.5 .
• BP6: Variant M-10086-A-G is Benign according to our data. Variant chrM-10086-A-G is described in ClinVar as [Benign]. Clinvar id is 693260.Status of the report is criteria_provided_single_submitter, 1 stars.
• BS1: High frequency in mitomap database: 0.0076
• BS2: High AC in GnomadMitoHomoplasmic at 1197

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
TRNG	TRNG.1			downstream_gene_variant

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
MT-ND3	ENST00000361227.2	c.28A>G	p.Asn10Asp	missense_variant	1/1			P1
MT-TG	ENST00000387429.1			downstream_gene_variant

Frequencies

GnomAD4 exome Cov.: 0

We have no GnomAD4 genomes data on this position. Probably position not covered by the project.

Mitomap GenBank AF: 0.0076 AC: 465

Gnomad homoplasmic AF: 0.021 AC: 1197 AN: 56433

Gnomad heteroplasmic AF: 0.000018 AC: 1 AN: 56433

Alfa AF: 0.00478 Hom.: 32

Mitomap

Hypertensive-end-stage-renal-disease

ClinVar

Significance: Benign

Submissions summary: Benign:1

Revision: criteria provided, single submitter

Submissions by phenotype

Leigh syndrome Benign:1

Benign, criteria provided, single submitter

clinical testing

Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine

Oct 17, 2019

The NC_012920.1:m.10086A>G (YP_003024033.1:p.Asn10Asp) variant in MTND3 gene is interpretated to be a Benign variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes: BA1 -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
Apogee2	Benign	0.28
Hmtvar	Pathogenic	0.59
AlphaMissense	Benign	0.32
BayesDel_addAF	Benign	-0.37	T
DEOGEN2	Benign	0.097	T
LIST_S2	Benign	0.63	T
MutationAssessor	Uncertain	2.2	M
MutationTaster	Benign	1.0	N
PROVEAN	Uncertain	-3.5	D
Sift	Benign	0.087	T
Sift4G	Benign	0.064	T
GERP RS		3.7
Varity_R		0.42

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs28358274; hg19: chrM-10087;